Sawai Pharmaceutical (OTCMKTS:SWPIF) Coverage Initiated at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell

Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell began coverage on shares of Sawai Pharmaceutical (OTCMKTS:SWPIF) in a research report report published on Monday, Stock Target Advisor reports. The firm issued an outperform rating on the stock.

Separately, Smith Barney Citigroup assumed coverage on Sawai Pharmaceutical in a research report on Monday. They set an outperform rating on the stock.

Shares of SWPIF stock opened at $48.17 on Monday. The business has a fifty day moving average of $47.26 and a 200 day moving average of $47.66. Sawai Pharmaceutical has a 1 year low of $45.12 and a 1 year high of $52.81.

Sawai Pharmaceutical Company Profile

Sawai Pharmaceutical Co, Ltd. manufactures, sells, imports, and exports pharmaceutical products in Japan and the United States. The company offers drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc.

Recommended Story: What are popular range trading strategies?

Receive News & Ratings for Sawai Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sawai Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.